New hope for newborns: safer seizure drug shows promise
NCT ID NCT07401433
First seen Feb 26, 2026 · Last updated May 01, 2026 · Updated 8 times
Summary
This study compared a newer seizure medicine, levetiracetam, to the standard treatment (phenobarbitone) in 260 newborns with seizures. The goal was to see if levetiracetam could stop seizures faster and with fewer side effects like sleepiness or feeding problems. Results will help doctors choose the best treatment for these fragile babies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEONATAL SEIZURES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gomal Medical College
Dera Ismāīl Khān, KPK, 29111, Pakistan
Conditions
Explore the condition pages connected to this study.